51 related articles for article (PubMed ID: 38472373)
1. Predicting isocitrate dehydrogenase status among adult patients with diffuse glioma using patient characteristics, radiomic features, and magnetic resonance imaging: Multi-modal analysis by variable vision transformer.
Usuzaki T; Inamori R; Shizukuishi T; Morishita Y; Takagi H; Ishikuro M; Obara T; Takase K
Magn Reson Imaging; 2024 Sep; 111():266-276. PubMed ID: 38815636
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of using a multiparametric magnetic resonance imaging-based radiomics model to distinguish glioma recurrence from pseudoprogression.
Fu FX; Cai QL; Li G; Wu XJ; Hong L; Chen WS
Magn Reson Imaging; 2024 Sep; 111():168-178. PubMed ID: 38729227
[TBL] [Abstract][Full Text] [Related]
3. Preoperatively Predicting Ki67 Expression in Pituitary Adenomas Using Deep Segmentation Network and Radiomics Analysis Based on Multiparameter MRI.
Li H; Liu Z; Li F; Shi F; Xia Y; Zhou Q; Zeng Q
Acad Radiol; 2024 Feb; 31(2):617-627. PubMed ID: 37330356
[TBL] [Abstract][Full Text] [Related]
4. Deep learning-based magnetic resonance imaging analysis for chronic cerebral hypoperfusion risk.
Yang M; Yang L; Zhang Q; Xu L; Yang B; Li Y; Cheng X; Zhang F; Liu M; Yu N
Med Phys; 2024 May; ():. PubMed ID: 38820428
[TBL] [Abstract][Full Text] [Related]
5. Novel Imaging Approaches for Glioma Classification in the Era of the World Health Organization 2021 Update: A Scoping Review.
Richter V; Ernemann U; Bender B
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791871
[TBL] [Abstract][Full Text] [Related]
6. Identifying key factors for predicting O6-Methylguanine-DNA methyltransferase status in adult patients with diffuse glioma: a multimodal analysis of demographics, radiomics, and MRI by variable Vision Transformer.
Usuzaki T; Takahashi K; Inamori R; Morishita Y; Shizukuishi T; Takagi H; Ishikuro M; Obara T; Takase K
Neuroradiology; 2024 May; 66(5):761-773. PubMed ID: 38472373
[TBL] [Abstract][Full Text] [Related]
7. Fusion Radiomics Features from Conventional MRI Predict MGMT Promoter Methylation Status in Lower Grade Gliomas.
Jiang C; Kong Z; Liu S; Feng S; Zhang Y; Zhu R; Chen W; Wang Y; Lyu Y; You H; Zhao D; Wang R; Wang Y; Ma W; Feng F
Eur J Radiol; 2019 Dec; 121():108714. PubMed ID: 31704598
[TBL] [Abstract][Full Text] [Related]
8. Predicting MGMT Promoter Methylation in Diffuse Gliomas Using Deep Learning with Radiomics.
Chen S; Xu Y; Ye M; Li Y; Sun Y; Liang J; Lu J; Wang Z; Zhu Z; Zhang X; Zhang B
J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743511
[TBL] [Abstract][Full Text] [Related]
9. MRI-based radiomics as response predictor to radiochemotherapy for metastatic cervical lymph node in nasopharyngeal carcinoma.
Xu H; Liu J; Huang Y; Zhou P; Ren J
Br J Radiol; 2021 Jun; 94(1122):20201212. PubMed ID: 33882240
[TBL] [Abstract][Full Text] [Related]
10. Multiparametric MR radiomics in brain glioma: models comparation to predict biomarker status.
He J; Ren J; Niu G; Liu A; Wu Q; Xie S; Ma X; Li B; Wang P; Shen J; Wu J; Gao Y
BMC Med Imaging; 2022 Aug; 22(1):137. PubMed ID: 35931979
[TBL] [Abstract][Full Text] [Related]
11. Machine learning-based radiomic, clinical and semantic feature analysis for predicting overall survival and MGMT promoter methylation status in patients with glioblastoma.
Lu Y; Patel M; Natarajan K; Ughratdar I; Sanghera P; Jena R; Watts C; Sawlani V
Magn Reson Imaging; 2020 Dec; 74():161-170. PubMed ID: 32980505
[TBL] [Abstract][Full Text] [Related]
12. Multimodal data fusion for cancer biomarker discovery with deep learning.
Steyaert S; Pizurica M; Nagaraj D; Khandelwal P; Hernandez-Boussard T; Gentles AJ; Gevaert O
Nat Mach Intell; 2023 Apr; 5(4):351-362. PubMed ID: 37693852
[TBL] [Abstract][Full Text] [Related]
13. MRI-Based Deep Learning Tools for MGMT Promoter Methylation Detection: A Thorough Evaluation.
Robinet L; Siegfried A; Roques M; Berjaoui A; Cohen-Jonathan Moyal E
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190181
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
